As cMyBP-C is heavily mutated in human cardiomyopathy, determining the mechanisms that contribute to disease progression in cardiomyopathies caused by MYBPC3 mutations and other sarcomere gene mutations is of critical importance. Here, MYBPC3 is linked to cardiomyopathy.